Forma Therapeutics Holdings, Inc.
Forma Therapeutics Holdings, Inc., a leading biopharmaceutical company based in the United States, is dedicated to transforming the lives of patients with rare diseases and cancers. Founded in 2010, Forma has made significant strides in drug discovery and development, focusing on innovative therapies that target specific genetic mutations.
With a strong emphasis on precision medicine, Forma Therapeutics is renowned for its unique approach to developing small molecule therapies, particularly in the areas of sickle cell disease and other haematological disorders. The company has achieved notable milestones, including advancing its lead product candidates through various stages of clinical trials, positioning itself as a key player in the biopharmaceutical industry.
Through its commitment to scientific excellence and patient-centric solutions, Forma Therapeutics continues to enhance its market position, striving to deliver transformative treatments that address unmet medical needs.
+34 vs industry average
Forma Therapeutics Holdings, Inc.’s score of 72 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Forma Therapeutics Holdings, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Forma Therapeutics Holdings, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Forma Therapeutics Holdings, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Forma Therapeutics Holdings, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Novo Nordisk A/S
Carbon Disclosure Project
Inherited from Novo Nordisk A/SThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Novo Nordisk A/SRE 100
Inherited from Novo Nordisk A/SClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project